Y.S.P. Southeast Asia Holding Berhad operates in the Pharmaceutical preparations sector. Y.S.P. Southeast Asia Holdings Bhd (Y.S.P.SAH) is a Malaysia-based company engaged in investment holding and provision of management services. Through its subsidiaries, Y.S.P.SAH operates in three segments: pharmaceutical trading, which is engaged in the import, export and trading in various kinds of pharmaceutical products; pharmaceutical manufacturing, which is engaged in the manufacturing of pharmaceutical products, and other operations, which is engaged in investment holding. During the year ended December 31, 2009, Y.S.P.SAH registered a total of 27 new products, of which 16 are manufactured in-house and the remaining 11 imported from its principal and overseas partners. On February 5, 2009, the Company incorporated a subsidiary with a 60% equity interest under the name of Sun Ten Southeast Asia Holding Pte. Ltd. In
our complete report available for purchase the company is compared to: CCM Duopharma Biotech Berhad, Kotra Industries Bhd and Hovid Berhad.